These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 16455181)

  • 1. Gene expression in normal urothelium depends on location within the bladder: a possible link to bladder carcinogenesis.
    Doherty SC; McKeown SR; Lopez JA; Walsh IK; McKelvey-Martin VJ
    Eur Urol; 2006 Aug; 50(2):290-301. PubMed ID: 16455181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profile in squamous cell carcinoma of the urinary bladder using complementary deoxyribonucleic acid microarray.
    Ewis AA; El-Samman E; Ali N; Kajimoto K; Shinohara Y; Ishikawa M; Kanayama HO; Baba Y
    Urol Oncol; 2007; 25(2):120-7. PubMed ID: 17349526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.
    Kawakami K; Enokida H; Tachiwada T; Gotanda T; Tsuneyoshi K; Kubo H; Nishiyama K; Takiguchi M; Nakagawa M; Seki N
    Oncol Rep; 2006 Sep; 16(3):521-31. PubMed ID: 16865252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
    Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
    Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) in bladder transitional cell carcinoma.
    Ham WS; Lee JH; Yu HS; Choi YD
    Urology; 2008 Oct; 72(4):921-6. PubMed ID: 18387660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural differences between the bladder dome and trigone revealed by mRNA expression analysis of cold-cut biopsies.
    Sánchez Freire V; Burkhard FC; Schmitz A; Kessler TM; Monastyrskaya K
    BJU Int; 2011 Jul; 108(2 Pt 2):E126-35. PubMed ID: 21244608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma.
    Mengual L; Burset M; Ribal MJ; Ars E; Marín-Aguilera M; Fernández M; Ingelmo-Torres M; Villavicencio H; Alcaraz A
    Clin Cancer Res; 2010 May; 16(9):2624-33. PubMed ID: 20406841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stages.
    Descotes F; Dessen P; Bringuier PP; Decaussin M; Martin PM; Adams M; Villers A; Lechevallier E; Rebillard X; Rodriguez-Lafrasse C; Devonec M; Paparel P; Perrin P; Lazar V; Ruffion A
    BJU Int; 2014 Feb; 113(2):333-42. PubMed ID: 24053469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of gene expression and cell-cycle signaling pathways by the EGFR inhibitor gefitinib (Iressa) in rat urinary bladder cancer.
    Lu Y; Liu P; Van den Bergh F; Zellmer V; James M; Wen W; Grubbs CJ; Lubet RA; You M
    Cancer Prev Res (Phila); 2012 Feb; 5(2):248-59. PubMed ID: 21982874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer.
    Ord JJ; Streeter EH; Roberts IS; Cranston D; Harris AL
    Br J Cancer; 2005 Aug; 93(3):346-54. PubMed ID: 16052224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
    Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
    Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX4 expression levels in urothelial bladder carcinoma.
    Gunes S; Yegin Z; Sullu Y; Buyukalpelli R; Bagci H
    Pathol Res Pract; 2011 Jul; 207(7):423-7. PubMed ID: 21680105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes.
    Wang X; Colby JK; Rengel RC; Fischer SM; Clinton SK; Klein RD
    Mol Carcinog; 2009 Jan; 48(1):1-13. PubMed ID: 18444251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis.
    Kanehira M; Harada Y; Takata R; Shuin T; Miki T; Fujioka T; Nakamura Y; Katagiri T
    Oncogene; 2007 Sep; 26(44):6448-55. PubMed ID: 17452976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring gene expression profile changes in bladder transitional cell carcinoma using cDNA microarray.
    Ying-Hao S; Qing Y; Lin-Hui W; Li G; Rong T; Kang Y; Chuan-Liang X; Song-Xi Q; Yao L; Yi X; Yu-Ming M
    Urol Oncol; 2002; 7(5):207-12. PubMed ID: 12644218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 isoenzyme mRNA expression pattern in human urinary bladder malignancies and normal urothelium.
    Brauers A; Manegold E; Buettner R; Baron JM; Merk HF; Jakse G
    Cancer Detect Prev; 2000; 24(4):356-63. PubMed ID: 11059566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of noninvasive primary urothelial tumours using microarrays.
    Aaboe M; Marcussen N; Jensen KM; Thykjaer T; Dyrskjøt L; Orntoft TF
    Br J Cancer; 2005 Nov; 93(10):1182-90. PubMed ID: 16265353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder.
    Otto W; Fritsche HM; Wild PJ; Wieland WF; Hartmann A; Burger M; Hofstädter F; Denzinger S
    Pathol Res Pract; 2011 Mar; 207(3):161-3. PubMed ID: 21247708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
    Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
    Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.